Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引:0
|
作者
Ashkan Emadi
Joel V. Chua
Rohit Talwani
Søren M. Bentzen
John Baddley
机构
[1] University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center,
[2] University of Maryland School of Medicine Department of Medicine,undefined
[3] University of Maryland School of Medicine Department of Pharmacology,undefined
[4] University of Maryland School of Medicine,undefined
[5] Institute of Human Virology,undefined
[6] University of Maryland School of Medicine Department of Epidemiology and Public Health,undefined
来源
Trials | / 21卷
关键词
COVID-19; Randomised controlled trial; protocol; SARS-CoV; imatinib; tyrosine kinase inhibitor; TKI; lysosomal sequestration; viral ABL-1 signalling; TKI-induced attenuation of vascular leak; TKI-induced prevention and treatment lung inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial
    Hosogaya, Naoki
    Miyazaki, Taiga
    Fukushige, Yuri
    Takemori, Sachiko
    Morimoto, Shinpei
    Yamamoto, Hiroshi
    Hori, Makoto
    Kurokawa, Tomoya
    Kawasaki, Yohei
    Hanawa, Michiko
    Fujii, Yasuhisa
    Hanaoka, Hideki
    Iwami, Shingo
    Watashi, Koichi
    Yamagoe, Satoshi
    Miyazaki, Yoshitsugu
    Wakita, Takaji
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    Kohno, Shigeru
    [J]. TRIALS, 2021, 22 (01)
  • [22] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial
    Panpan Liu
    Zhijun Huang
    Mingzhu Yin
    Chun Liu
    Xiang Chen
    Pinhua Pan
    Yehong Kuang
    [J]. Trials, 21
  • [23] Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial
    Liu, Panpan
    Huang, Zhijun
    Yin, Mingzhu
    Liu, Chun
    Chen, Xiang
    Pan, Pinhua
    Kuang, Yehong
    [J]. TRIALS, 2020, 21 (01)
  • [24] Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial
    Naoki Hosogaya
    Taiga Miyazaki
    Yuri Fukushige
    Sachiko Takemori
    Shinpei Morimoto
    Hiroshi Yamamoto
    Makoto Hori
    Tomoya Kurokawa
    Yohei Kawasaki
    Michiko Hanawa
    Yasuhisa Fujii
    Hideki Hanaoka
    Shingo Iwami
    Koichi Watashi
    Satoshi Yamagoe
    Yoshitsugu Miyazaki
    Takaji Wakita
    Koichi Izumikawa
    Katsunori Yanagihara
    Hiroshi Mukae
    Shigeru Kohno
    [J]. Trials, 22
  • [25] Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial
    Li-An K. Brown
    Nick Freemantle
    Judy Breuer
    Hakim-Moulay Dehbi
    Kashfia Chowdhury
    Gemma Jones
    Felicia Ikeji
    Amalia Ndoutoumou
    Krishneya Santhirakumar
    Nicky Longley
    Anna M. Checkley
    Joseph F. Standing
    David M. Lowe
    [J]. Trials, 22
  • [26] Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial
    Brown, Li-An K.
    Freemantle, Nick
    Breuer, Judy
    Dehbi, Hakim-Moulay
    Chowdhury, Kashfia
    Jones, Gemma
    Ikeji, Felicia
    Ndoutoumou, Amalia
    Santhirakumar, Krishneya
    Longley, Nicky
    Checkley, Anna M.
    Standing, Joseph F.
    Lowe, David M.
    [J]. TRIALS, 2021, 22 (01)
  • [27] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Jonathan Rilinger
    Winfried V. Kern
    Daniel Duerschmied
    Alexander Supady
    Christoph Bode
    Dawid L. Staudacher
    Tobias Wengenmayer
    [J]. Trials, 21
  • [28] A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
    Rilinger, Jonathan
    Kern, Winfried V.
    Duerschmied, Daniel
    Supady, Alexander
    Bode, Christoph
    Staudacher, Dawid L.
    Wengenmayer, Tobias
    [J]. TRIALS, 2020, 21 (01)
  • [29] Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial
    Alonso Soto
    Fiorella Krapp
    Alex Vargas
    Lucía Cabrejos
    Enrique Argumanis
    Patricia L. García
    Karina Altamirano
    Martín Montes
    Pamela R. Chacón-Uscamaita
    Patricia J. García
    [J]. Trials, 22
  • [30] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
    McMahon, James H.
    Lau, Jillian S. Y.
    Roney, Janine
    Rogers, Benjamin A.
    Trubiano, Jason
    Sasadeusz, Joseph
    Molton, James S.
    Gardiner, Bradley
    Lee, Sue J.
    Hoy, Jennifer F.
    Cheng, Allen
    Peleg, Anton Y.
    [J]. TRIALS, 2020, 21 (01)